290 related articles for article (PubMed ID: 17277108)
1. Differential CD40/CD40L expression results in counteracting antitumor immune responses.
Murugaiyan G; Agrawal R; Mishra GC; Mitra D; Saha B
J Immunol; 2007 Feb; 178(4):2047-55. PubMed ID: 17277108
[TBL] [Abstract][Full Text] [Related]
2. Functional dichotomy in CD40 reciprocally regulates effector T cell functions.
Murugaiyan G; Agrawal R; Mishra GC; Mitra D; Saha B
J Immunol; 2006 Nov; 177(10):6642-9. PubMed ID: 17082576
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines.
Ceglia V; Zurawski S; Montes M; Kroll M; Bouteau A; Wang Z; Ellis J; Igyártó BZ; Lévy Y; Zurawski G
Front Immunol; 2021; 12():786144. PubMed ID: 35095862
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.
Liu Y; Zhang X; Zhang W; Chen Z; Chan T; Ali K; Jia Z; Xiang J
Cancer Gene Ther; 2002 Feb; 9(2):202-8. PubMed ID: 11857039
[TBL] [Abstract][Full Text] [Related]
5. CD40L expression by CD4
Durlanik S; Loyal L; Stark R; Sercan Alp Ö; Hartung A; Radbruch A; von Herrath M; Matzmohr N; Frentsch M; Thiel A
Eur J Immunol; 2016 Nov; 46(11):2566-2573. PubMed ID: 27562840
[TBL] [Abstract][Full Text] [Related]
6. CD40 signalling induces IL-10-producing, tolerogenic dendritic cells.
Tuettenberg A; Fondel S; Steinbrink K; Enk AH; Jonuleit H
Exp Dermatol; 2010 Jan; 19(1):44-53. PubMed ID: 19889024
[TBL] [Abstract][Full Text] [Related]
7. Differential requirements of T cell subsets for CD40 costimulation in immunity to Blastomyces dermatitidis.
Wüthrich M; Fisette PL; Filutowicz HI; Klein BS
J Immunol; 2006 May; 176(9):5538-47. PubMed ID: 16622023
[TBL] [Abstract][Full Text] [Related]
8. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
[TBL] [Abstract][Full Text] [Related]
9. Influenza-induced, helper-independent CD8+ T cell responses use CD40 costimulation at the late phase of the primary response.
Seah SG; Brady JL; Carrington EM; Ng WC; Sutherland RM; Hancock MS; La Gruta NL; Brown LE; Turner SJ; Lew AM; Zhan Y
J Leukoc Biol; 2013 Jan; 93(1):145-54. PubMed ID: 23108101
[TBL] [Abstract][Full Text] [Related]
10. Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection.
Sia JK; Bizzell E; Madan-Lala R; Rengarajan J
PLoS Pathog; 2017 Aug; 13(8):e1006530. PubMed ID: 28767735
[TBL] [Abstract][Full Text] [Related]
11. CD40-CD40 ligand interaction between dendritic cells and CD8+ T cells is needed to stimulate maximal T cell responses in the absence of CD4+ T cell help.
Hernandez MG; Shen L; Rock KL
J Immunol; 2007 Mar; 178(5):2844-52. PubMed ID: 17312128
[TBL] [Abstract][Full Text] [Related]
12. Synergistic anti-tumor responses after administration of agonistic antibodies to CD40 and IL-2: coordination of dendritic and CD8+ cell responses.
Murphy WJ; Welniak L; Back T; Hixon J; Subleski J; Seki N; Wigginton JM; Wilson SE; Blazar BR; Malyguine AM; Sayers TJ; Wiltrout RH
J Immunol; 2003 Mar; 170(5):2727-33. PubMed ID: 12594303
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells.
Li Q; Grover AC; Donald EJ; Carr A; Yu J; Whitfield J; Nelson M; Takeshita N; Chang AE
J Immunol; 2005 Aug; 175(3):1424-32. PubMed ID: 16034078
[TBL] [Abstract][Full Text] [Related]
14. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
15. Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent.
McDowell MA; Marovich M; Lira R; Braun M; Sacks D
Infect Immun; 2002 Aug; 70(8):3994-4001. PubMed ID: 12117904
[TBL] [Abstract][Full Text] [Related]
16. Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand.
Wesa A; Galy A
BMC Immunol; 2002 Oct; 3():14. PubMed ID: 12385649
[TBL] [Abstract][Full Text] [Related]
17. Enhanced protective immunity derived from dendritic cells with phagocytosis of CD40 ligand transgene-engineered apoptotic tumor cells via increased dendritic cell maturation.
Parameswaran S; Khalil M; Ahmed KA; Sharma RK; Xiang J
Tumori; 2015; 101(6):637-43. PubMed ID: 25983089
[TBL] [Abstract][Full Text] [Related]
18. Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection.
Shedlock DJ; Whitmire JK; Tan J; MacDonald AS; Ahmed R; Shen H
J Immunol; 2003 Feb; 170(4):2053-63. PubMed ID: 12574376
[TBL] [Abstract][Full Text] [Related]
19. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
[TBL] [Abstract][Full Text] [Related]
20. Antitumor immune responses derived from transgenic expression of CD40 ligand in myeloma cells.
Liu Y; Qureshi M; Xiang J
Cancer Biother Radiopharm; 2002 Feb; 17(1):11-8. PubMed ID: 11915168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
